Reducing dementia drug risk
The over-prescription of antipsychotic medication to people with dementia in care will be targeted in a new million-dollar project led by UNSW researchers.
Headed up by UNSW Scientia Professor Henry Brodaty, the project will receive Federal Government funding under its Aged Care Service Improvement and Healthy Ageing Grants Fund.
In making the announcement, the Minister for Mental Health and Ageing, Mark Butler, said it was important to improve the support available to people with dementia, including best practice medication management.
"There is strong evidence of adverse effects of polypharmacy in older people and of the benefits of deprescribing generally and antipsychotics particularly," says Professor Brodaty, who heads the Dementia Collaborative Research Centre, based at UNSW Medicine.
The project, Halting Antipsychotic use in Long Term Care (HALT), is a collaboration between consumers, aged care providers, staff, GPs, Medicare Locals and researchers to improve outcomes for people with dementia in care.
"We think there will be a reduction in complications, rates of decline and mortality without consequently increasing behavioural and psychological symptoms," says Professor Brodaty, who is also with UNSW's Centre for Healthy Brain Ageing.
Have your say...
The approval of your comment is at the discretion of this article's publisher. Write your comment with the following in mind to ensure the highest likelihood of it being approved:
- No promotional undertones
- No use of profanity
- Good spelling, grammar and layout
- Check punctuation, language and missing words
- No use of aggression
- No unsubstantiated claims
We reserve the right to remove comments at our discretion.
Your name is used alongside Comments.